Detalhe da pesquisa
1.
Zanubrutinib plus cytarabine in patients with refractory/relapsed primary central nervous system lymphoma.
Acta Haematol
; 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38408440
2.
A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphoma.
J Neurooncol
; 163(1): 39-46, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35733032
3.
Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma.
Analyst
; 148(15): 3594-3602, 2023 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403840
4.
Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids through Functionally Tunable Paramagnetic Separation.
Angew Chem Int Ed Engl
; 62(29): e202305668, 2023 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216424
5.
Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China: a propensity-score matched multicenter study.
Ann Hematol
; 101(10): 2139-2148, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859066
6.
Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis.
J Clin Lab Anal
; 36(10): e24689, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098043
7.
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
BMC Ophthalmol
; 20(1): 189, 2020 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32397978
8.
The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphoma.
Ann Hematol
; 98(4): 923-930, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30729282
9.
Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
Invest New Drugs
; 36(4): 571-580, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29504068
10.
Elevated expression of the EZH2 gene in CALR-mutated patients with primary myelofibrosis.
Ann Hematol
; 97(7): 1193-1208, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29560522
11.
Highly Tumorigenic Diffuse Large B Cell Lymphoma Cells Are Produced by Coculture with Stromal Cells.
Acta Haematol
; 139(4): 201-216, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29791894
12.
Enhanced clinical outcomes with radiotherapy in diagnostically challenging intracranial plasmacytomas: Analysis of 190 cases.
Cancer Med
; 13(4): e7017, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457205
13.
Prospective nested case-control study of feature genes related to leukemic evolution of myelodysplastic syndrome.
Mol Biol Rep
; 40(1): 469-76, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065273
14.
Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma.
Front Immunol
; 14: 1191033, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37426647
15.
Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.
Hematology
; 28(1): 2243424, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545411
16.
Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma.
Front Oncol
; 13: 1098785, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182159
17.
Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.
Neurooncol Adv
; 5(1): vdac181, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879663
18.
Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma.
Discov Oncol
; 14(1): 205, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971595
19.
High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers.
Front Mol Biosci
; 10: 1257079, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028545
20.
Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime.
Mol Ther Oncolytics
; 25: 288-304, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35663228